According to Drug Diversion Digest, the number of doses lost to employee misuse and theft yearly adds up to $47.2 billion. Unfortunately, most solutions on the market cannot fulfill the promise of identifying and predicting drug diverters because they can’t pull all data from all sources.
Not so with ANiGENT, the team created a surveillance process incorporating a facility’s ability to track, monitor, and collect information pulled from all data sources. The solution is called the Medication Administration Analysis Program (MAAP). After five years of benchmark studies, MAAP demonstrated that it could proactively tackle drug diversion prevention and significantly reduce inefficiencies.
MAAP can monitor anyone involved in the compounding, dispensing, administering, and wasting of medications. It follows all substances at risk of being diverted, including patches, infusions, syringes, oral liquids, and injectables. MAAP’s capabilities also include tracking data from any location, department, or procedure area where high-risk substances are handled, never bypassing any room or location.
ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refinements in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce actionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements. To learn more about ANiGENT and MAAP Analytics, visit ANiGENT.com.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Drug Diversion Monitoring, Diversion Prevention
